Video

Biotech firms encounter several challenges in clinical trials, including limited funds, trial complexity, patient recruitment difficulties, talent shortages, and the need to develop a competitive advantage.

Get in touch with us, and start shaping the future.

Discover how the principles of Decision Quality can empower project developers to make better bidding decisions.

Get in touch with us, and start shaping the future.

Energy transition to a lower carbon economy is a result of interactions among Energy Producers/Consumers, Policy Makers, Technology Providers, and Financial Institutions.

Dr. Sang-Won Kim

Partner

Houston, USA

Get in touch with us, and start shaping the future.

Join us for the SDG “Pharma Decision Day 2024” hosted by Bayer Pharmaceuticals, with confirmed participation from Merck KGaA, Boehringer Ingelheim, AstraZeneca, Lundbeck and Sanofi.

Our special event is focused on Decision Science in the pharmaceutical industry. We will provide a platform for open discussions on the importance of decision making in pharma and the exchange of best practices across R&D, Commercial and BD functions. This one-day event, taking place in Berlin, is an excellent opportunity for participants from pharmaceutical companies and biotech firms to learn how the industry is leveraging Decision Quality (DQ) and to share experiences.

Days

Hours

Minutes

Date

24th September, 2024

Location

Bayer Pharmaceuticals,
Müllerstr. 178, 13353 Berlin

Time

8:30 - 18:00

Topics

Session 1. Framing Decisions and Establishing Governance

Key Steps to Stakeholder Management and Effective Cross-Functional Collaboration

Effective stakeholder management hinges on framing decisions correctly and establishing robust governance. This stream emphasizes the importance of cross-functional collaboration in enhancing decision quality across pharmaceutical operations. Discussions will center on strategies for fostering collaboration among R&D, commercial, medical, regulatory, value and access, BD&L and other critical departments.

Session 2. Clear Values and Trade-offs in Asset and Portfolio Management

Aligning Strategy, Capabilities and Resources in Pharma Development

Clear values and trade-offs are essential in pharmaceutical asset and portfolio management to ensure Decision Quality. This stream delves into strategic decision-making processes that prioritize projects, allocate resources effectively, and manage risks within diverse portfolios. Attendees will discuss frameworks that align portfolio decisions with organizational goals and market opportunities, optimizing strategy execution and resource allocation for sustainable growth.

Session 3. Future Trends and Leadership Excellence

Improving Decision Quality in Pharma

As the pharmaceutical industry evolves, trends like AI integration, personalized medicine, and reimbursement complexities shape decision-making. Leaders drive continuous improvement by fostering a culture of high-quality decisions. Embracing transparency and agile approaches enables sustainable growth in a dynamic healthcare landscape.

Limited Places Still Available!

If you work in a biotech or pharma company, this event is a great opportunity for you.

This event opens up discussions on the importance of decision making in the pharmaceutical industry and addresses questions like:

How do we strengthen collaboration among R&D and Commercial?
How do we prioritize indications and allocate resources?
How do future trends in pharma affect drug development decisions today?

We have a few remaining spots for the “Pharma Decision Day 2024”, and they will be awarded based on individual applications. This is your opportunity to share why you’re passionate about the event and the unique insights you can contribute.

Don’t miss out! With limited space available, make sure to apply now and explain why you should be part of this exclusive gathering.

Agenda

08:30 – 09:30

Breakfast & Networking

09:30 – 10:00

Opening Speech

10:00 – 12:15

Keynote: Elevating Decision Quality: Leadership Collaboration, Strategy

Speed Dating: Six Elements of Decision Quality

Presentation: Cover Your Ass? Change Management in Uncertain Time

Panel: Unlocking Potential: Cross-Functional Collaboration in Pharma

12:15 – 13:15

Lunch

13:15 – 14:45

Foresight Workshop: Driving Pharma´s Future Today

Presentation: Future Trends in Pharmaceutical Pricing & Reimbursement and Impact on Portfolio Decisions

15:00 – 16:40

Presentation: Bringing R&D to Life – Challenges and Opportunities for Acceleration

Presentation: Fixed Values, Flexible Decisions

Panel: From Trade-offs to Triumph: Strategic Pharma Portfolio Management

16:45 – 18:00

Networking & Drinks

Shaping Tomorrow

Empowering Strategic Decisions in Pharma

In the pharmaceutical industry, where innovation is constant and uncertainty is a given, the ability to make sound strategic decisions is crucial. Our event will explore the essential role of Decision Quality and analytics in managing pharmaceutical assets and portfolios as well as navigating the path to commercialization.

This one-day gathering provides a unique opportunity to:

Learn about Decision Quality (DQ) principles and their impact on strategic choices.

Engage in peer-to-peer exchanges and learn from others.

Share your experiences and insights and contribute to the collective wisdom of our field.

Contact Us

Join us and discuss what it takes to build a resilient yet innovative development organization and drive your company toward long-term business success.

We look forward to your participation and the exchange of ideas that will help elevate the standards of decision making in the pharmaceutical industry.

Dr. Mark Seidler

CEO

Duesseldorf, Germany

Dr. Florian Methling

Principal

Duesseldorf, Germany

The offshore wind industry has been going through some challenging times in the recent past and there is significant uncertainty with respect to cost, supply chain deliverability and commercial terms. Nevertheless, the industry is poised for significant increases in capacity, competition, and investment with improved technology.

The rights to development of an offshore wind park are auctioned by national regulators and comprise both price (subsidy or payment) and non-price criteria. Still, an offshore wind auction strategy is more than bidding optimization. It is a long-term strategy condensed into a bid – with major challenges to consider and resolve.

Key challenges include cost management and supply chain resilience to ensure project profitability. It includes the intensifying competition and evolving business models, ranging from hydrogen and other green fuels production to thermal, electrical, or chemical energy storage. This necessitates developers to navigate uncertainties surrounding economics, subsidies, and infrastructure availability at the time of bidding.

Moreover, the emergence of non-price auction criteria, such as environmental sustainability and innovation, urges developers to adopt alternative approaches.

In this dynamic landscape, success hinges on developing creative and robust strategies that go beyond conventional bidding tactics. Furthermore, a comprehensive quantitative probabilistic evaluation to identify the best strategies and to understand how to improve them further. This will allow companies to embrace long-term vision, adaptability, and innovation.

1. Costs & Supply Chain:

These issues are hampering the profitability of offshore wind projects, requiring measures to stabilize/share costs and build supply chain capacity and resiliency.

Challenges

Inflation & Project Disruptions:

Offshore wind cost increased by ~40% from ’19 – ‘22; 10+ projects put on hold.

Resolutions

Long-Term Supplier Contracts:

Stabilize costs by securing long-term contracts with diverse suppliers.

Supply Chain Capacity:

Current offshore wind supply chain can deliver ~7 GW/yr, needs grow 3x in the next few years.

Cost-Sharing Relationships:

Protect margin with cost-sharing strategies and introduce inflation protection in offtake agreements.

Interest Rates:

EU rates increased ~5% from ‘19 – ’23, and project financing has become more challenging.

Standardization:

Standardize offshore wind equipment & design to improve efficiency: e.g., cap wind turbine size.

2. Competition

The attractiveness of the industry is resulting in more competitive auctions and costlier bids, underscoring the need for optimization of operations and resources.

Challenges

Net Zero Goals:

Have driven new players, such as O&G companies w/ deep pockets, into the wind industry.

Resolutions

Competitive Edge:

Identify a niche, e.g., market or technology, and understand competitor positions.

Uneven Playing Field:

New players may accept lower ROIs as a part of a broader decarbonization strategy.

Portfolio Resource Allocation:

Allocate resources effectively by comparing value from various countries/markets.

Commoditization:

The offshore wind industry is largely commoditized, enabling easier access for new competitors.

Partnerships:

To share risk and get local or technical expertise into the project development.

3. Business Model

New business models, beyond traditional CfD’s and PPA’s, such as hydrogen production, energy storage and offshore islands, require developers to pinpoint the optimal strategy.

Challenges

Increased Uncertainty:

The new business models, are subject to substantially larger uncertainties.

Resolutions

Expand Options:

Maximize the project’s value by strategizing early: from business model, bidding, building and final farm down

Unclear Subsidies:

Lack of clarity on e.g., hydrogen subsidy award and restrictions.

Long-Term Offtakes:

Secure long-term offtake agreements, independent of business model, to enable profitable farm-downs.

Infrastructure:

The buildout of infrastructure may not match needs or timing requirements of different business models.

Infrastructure Partnerships:

Partner with infrastructure players and other developers to share risk and cut timelines.

4. Non-Price Criteria

Non-price auction criteria such as environmental criteria, innovation and integration requires developers to consider alternative approaches to project development.

Challenges

Trade-Offs:

Inclusion of non-price criteria requires new strategic alternatives and challenging trade-offs

Resolutions

Maximize Attractiveness to Regulator:

Take a broad view and consider alternatives to improve across the range of auction criteria.

Untransparent Measurement:

Unclear measurement of non-price criteria can make bidding untransparent and unpredictable.

Broader Partnership:

Allocate resources effectively by comparing value from various countries/markets.

Ability to Deliver:

Proving the ability, intention and speed of project delivery will become increasingly important.

Multi-Criteria Evaluation:

Compare a range of strategies across financial and non-financial criteria.

Auction Stratgey

SDG provides a decision-science based auction strategy framework for developing and evaluating alternative auction approaches.

Publications

Explore further insights from our experts by checking out our publications.

Publications

Charting the Road to Energy Transition

Publications

Climate Engineering and Climate Tipping-Point Scenarios

Publications

Techniques to Maximize Value from CCUS Decisions at Every Stage

Publications

Offshore Wind Auctions: Challenges & Resolutions

Harvard Business Review has featured an article from Carl Spetzler and Peter Hopper, who leads the firm’s Hong Kong office.

Their article, “You Can’t Make Good Predictions Without Embracing Uncertainty,” discusses how too often experts labor to produce exquisitely precise and specific scenarios of how the future will unfold, shrugging off uncertainty on the grounds that the future is, ultimately, unknowable. But the uncertainty is no excuse for less rigor or clarity. A consistent, quantitative perspective on uncertainty not only builds the best foundation for making good management decisions but also provides a platform for developing a shared understanding of trade-offs, bridging disagreement and establishing accountability.

To read the full article, which includes an example of a consumer brand company rebalancing its sourcing locations, click here.

Publications

Explore further insights from our experts by checking out our publications.

Publications

How to Make Strategic Trade-Offs

Publications

A 4-Step Process to Help Senior Teams Prioritize Decisions

Publications

An Organization-Wide Approach to Good Decision-Making

Publications

Johnson Quantile-Parameterized Distributions

Publications

“Quantile-Parameterized Distributions”

Publications

Three Things Every Executive Should Know About Risk

Publications

Closing the Decision Quality Gap

Publications

Reexamining Discrete Approximations to Continuous Distributions

Publications

You Can’t Make Good Predictions Without Embracing Uncertainty

On most decision analysis projects, decision analysts weight the P10, P50 and P90 assessments with probabilities such as 25%, 50%, 25% or 30%, 40%, 30%. In this paper [$], Dr. Hammond (Chevron) and Professor Eric Bickel carefully examine the accuracy of these and other competing methods.

Published in 2013 in Decision Analysis. The abstract is free and the paper is available for purchase at this link.

Publications

Explore further insights from our experts by checking out our publications.

Publications

How to Make Strategic Trade-Offs

Publications

A 4-Step Process to Help Senior Teams Prioritize Decisions

Publications

An Organization-Wide Approach to Good Decision-Making

Publications

Johnson Quantile-Parameterized Distributions

Publications

“Quantile-Parameterized Distributions”

Publications

Three Things Every Executive Should Know About Risk

Publications

Closing the Decision Quality Gap

Publications

Reexamining Discrete Approximations to Continuous Distributions

Publications

You Can’t Make Good Predictions Without Embracing Uncertainty

Peter Hopper explains how the firm’s Decision Quality approach helps leaders and teams reassess and reframe their most critical decisions to enhance clarity, achieve alignment, and ultimately identify the best alternative to execute.

Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren

Video laden

YouTube immer entsperren

Energy & Natural Resources

Life Science

Technology & Communication

Consumer Products

Aerospace

Engineering

Infrastructure

Business Strategy

Portfolio Management

Risk Analysis & Scenario Planning

Capital Investment

Business Planning & Forecasting

Asset Strategy

Organization & Decision Process Design

M&A

Our People

Decision Quality

Our Books

Partner & Sponsoring

Your Career

Locations

Our Podcast

40+ Years of SDG

Get in touch with us, and start shaping the future.

Get in touch with us, and start shaping the future.

Get in touch with us, and start shaping the future.

Date

Location

Time

Topics

Limited Places Still Available!

Agenda

Shaping Tomorrow

Empowering Strategic Decisions in Pharma

This one-day gathering provides a unique opportunity to:

Contact Us

1. Costs & Supply Chain:

Challenges

Inflation & Project Disruptions:

Resolutions

Long-Term Supplier Contracts:

Supply Chain Capacity:

Cost-Sharing Relationships:

Interest Rates:

Standardization:

2. Competition

Challenges

Net Zero Goals:

Resolutions

Competitive Edge:

Uneven Playing Field:

Portfolio Resource Allocation:

Commoditization:

Partnerships:

3. Business Model

Challenges

Increased Uncertainty:

Resolutions

Expand Options:

Unclear Subsidies:

Long-Term Offtakes:

Infrastructure:

Infrastructure Partnerships:

4. Non-Price Criteria

Challenges

Trade-Offs:

Resolutions

Maximize Attractiveness to Regulator:

Untransparent Measurement:

Broader Partnership:

Ability to Deliver:

Multi-Criteria Evaluation:

Auction Stratgey

Publications

Charting the Road to Energy Transition

Climate Engineering and Climate Tipping-Point Scenarios

Techniques to Maximize Value from CCUS Decisions at Every Stage

Offshore Wind Auctions: Challenges & Resolutions

Publications

How to Make Strategic Trade-Offs